{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"muscular-dystrophy-dystroglycanopathy-congenital-with-brain-and-eye-anomalies-type-a-4","columns":[{"gene":"","key":"population-b917fa63703775fadd1c","label":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","mondoId":"MONDO:0009678","onsetQualifier":null,"originColumnKey":"MONDO:0009678/OMIM:253800","originalViews":[{"key":"MONDO:0009678/OMIM:253800","label":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","scopeLabel":"OMIM:253800","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["01d6c8dae3effbf4fbb87eb2ce9170df9cb92d3e53ac72192087e762ff88ab5d","106da8d64a54e35ab7db23fe9aa1ca5279a7c0bf1036ed33b3b19cd33f18825e","12b2c1b278e9014f7d96a79d17e3b52aaa6811d76d6f68059fc6be77413baf38","1331cae249c03cdcc42b5ee6fcbdc402178657499fe63b102d68d8352bca8be1","13d3b0cd1ce3510bc4ac82f45941eec3eb2c655877db0188ac659fa8a2b38d37","1f1a1a2663c9aa89582b5de2a42db9724d02e43ac1ec0db0bb2470c95ffa3e85","1fc070ba3cb3c7e94181f6654d63232d2e4004e026236c465c9585538c8872fc","230b2aef56b6aab13addef357652f80ed8fd21543509a5bb9351f2703f4e79a8","2345d29d49c9aef0495106b39b25863ada0596d6d0bb87276f80e4296afc9eda","36db523fefa818bb83a48caec02e110b8debf41ff754c0e2cd46342ca7d7d746","3876023538154185afb72a1831e4d6130417b1d6d581e7f82f86a5a15f184529","3fb255b5693c87673d4dbc977fd0540f59142157d1201d1b520e2ed4d4e370fe","411bb5245af9fc897eece83ec97279ae049b837aed0c5d7d5d94b4dac3c31045","47fd85b053420d164e5ab13e6e16cc0625d5cf95aeeb182d338795102ce18ec6","4a8118a93ee080c9e558c5603e1b9a07e51caa4bedb40e610d0971f0452d9104","4d581d771f77824327cda0d8fa5b817f7aba69265c106c709d3b379c9ca4eeef","5035dde5f357c9711ded02dd5e0edd8568c26e5e2e9807be3f9b53c2edb48d69","5542cd35e94766727e6e2442b264bdcbdaefea432a00502568e5caf90870e220","57ca522f0160650b58c3a5fcbfd1b36fa50549b8c25eb07106da703c64b7316e","5b74dd1f7f1027057130ce9031873fb4edc4be839299bc9ca9cc7dc2d4a17a5d","5c78e932dd6268028ac9582edbdda9da8063d379402292e141f0782bc5925157","6ef18b300229a17658c477dbc5c799aeca2d661051b5f3f088ec165a9e903d80","755a3f40791f4c2c8516d11d16c40fb907c849c276157896d11adba74f1897bf","884bae46350dc5fa782e9cb3514e3c546aba46b6dbb8f2f3cc70339a996c7cb8","891b1f7be8e06e90b75477480db250573fc65839f40f6685ceb9efa4da85fa66","89c11278d512a210eb68617c2b6de66a7cdb33fb0ea6ea6b3e6a0ab0d86c0b53","90758ddf94bd6ebe5fdc162654f9852c204f43f19164cb8bc254507c1b3a5c0f","9adcd3a90079607a29feedc20a9190763772c607cc503651ed2c935401078e17","a2dd666ea48d136029f190796852309a45b02b54ad0353ae9751f826ebc32e97","a3c44e48fcf0a16bca4a4d1092f90f6b0538784a24d118209747038099191524","ac6b4e5e7c033a56ebf2d5a7069605867c3c69000272d2a09f9a488c444934f2","b67024d16775cb097c1c1bbb1acf849067a6c537d548507dca6d38669ce7fc52","bf1cf27ff92bd9724d76c6d2ac950b7facf096c1dcee3080614e6419d61131af","c610a203ae921f29fadc9709b114371d7f9ed531cf23a00f69fa09e2e4573298","e1160e721c5c3781c4d436cebbc9ae610d696c22f56853887f0c5557f9311554","e2a872dfa4b9ea0d336bb85c9df198ce22f94c821285179859a29d1aa5f7cedd","ec15dfdb3042f6223a9e1ceecb9e2de35a7f7dd39541607b7c00b4d1b6d772ec","f0c2b834d28e924a8cf54c740e78d7eef0eb4932512003c49361b3935ed18546","f1172facf764cf9fb526b7201f66cb596234851d8c374ef58f3e514f3e874ba4","fa7c499dc4bcf4b65ac3e978f632b3176466637979aec5fe00756b4004aa95d7","fe6a843a4eb33abd8bca7d7c912a7ad39ef79429c75bbd94fd94463d253a7b41","fe84b132560fd53c92681a3816949bd9f9470e12507991a903f476d5b123092c"],"recordQualifiers":{},"scopeLabel":"OMIM:253800","sourceIds":["OMIM:253800"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-efdf4a81ba85cc1d0fa4","label":"Congenital muscular dystrophy, Fukuyama type","mondoId":"MONDO:0009678","onsetQualifier":null,"originColumnKey":"MONDO:0009678/ORPHA:272","originalViews":[{"key":"MONDO:0009678/ORPHA:272","label":"Congenital muscular dystrophy, Fukuyama type","scopeLabel":"ORPHA:272","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["022bf601fc7f9106e8500ba6b1874e5dc8fa0d297680bc566d84ea88eb4bdb79","05fee9cfcb83b88957e7f46992ec0cc9f430fd776fee5f1e8d0ebe92de4a6ae3","16c7459951193b3e5cef9b8de5b6baecc91d5ba6502dc5c2899588cbb5e76720","1a4cebca6e9fa3bbce17e49efadd5fae2c688fd6ad9670839fd514548da71548","2fdc5b85846f5ced76b9281c0c814af10e6b072f89b62801ba407fdaff85e64d","3090253e202b0ca3dc059f1836a74de17496040a643ee2d52f947f065301cb32","338875fbb8d471e9cbaf05db2c09ea761316941083a4c606ce876ef975127cbe","3cb3c1cf8fc24e176041ccb8741103f45ede92a19d9595485f2d05f3dfef1680","3ea7315ab9d5df719077b062acfa7ebc9b98a2c976563e465e90068a2805fb0b","4170b3594e52edd018eee9aaec1a20eda4421b6990753d233471352665e61dfe","465b924da815a551cffc229bb698e7c7eb0f18b4549f12a614f5261148e4b08f","5c742b89d1e6aad08adf5d89b5ed59d4e1c9685ab7abdce40e0adde16e38fa5b","7aee4808364ebb832ab91a6bd1ff06d100bc03d69cc3d9f2f37fbf490d4c16c7","7cd659b613f314d8e7fb494f90c1076a0e72e0fe9afc644d270835e9c8750721","950c6af690e1900911e03ca9f7fda2e7c4abf47231b9d1a59780172b94aa8edf","9dab69f2b9609fe3f50ba499e9e56b2117cc5ced5fa9af2d96226f480b626402","a5a0a99ed900a6d352d721f877e8c5d4af747fd20ff0929bdaee5d37beed90d1","af382f0edccd8a398a6d357a17edcd26b7127571593e7063b41ac1736ff7364d","c0e24d3e43169dac8d91470f62c6eabc697a466f6cb03061f95922fa08b136ea","d1697a181af6eec77c1e9ad9d59b9232f4a663b2ba4048a12a9d5b4877e22cb8","d5d2d2a10cd14c18425f66456faeea68b09252ff99674d3c3323bc6faf9c9499","d670c5b9e00cc860307c4ca43a40c2c0ee09957f002d1d69649a4fa18b45ad02","dae35e6611e274cbc1021bcdc02e878963ae9fbe56713a4eb80db5fb05a59bc4","e0de48ced076affc22cdd5dff604b26e43349e198be9ba3f7c90fa78e88d5d55","e10d805c9dc27f9ff16ad583a1500af4d9bd41cdcf66ea50246212534c13ba06","e5cb0904ef56c21f0179344643f0c021591a3ec165618405ddda3405a57b307b","e8790b4b3d4f2d85974ce734b2c8befe89cdde06cf103a088789dc3ae5c88739","e962f74c23726419260fc33e34d1058c6b7f2cb85ae779aecb43fb751ac1e625","f3639f9691df523d5d4baeac49290f046d81fb4de1a7f9c30c58c347ba9d0264","f6a090e8589390d3ff504bf5cf229f3f3df480b03fa2ce089971cf4c1d8f7249","f9ac13a8d024eddc263dc4c3e81f62ee9e6ec5f75acc0a90e9b70ca225f9a269"],"recordQualifiers":{},"scopeLabel":"ORPHA:272","sourceIds":["ORPHA:272"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-b917fa63703775fadd1c","population-efdf4a81ba85cc1d0fa4"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000496","HP:0001274","HP:0031882","HP:0007370","HP:0001284","HP:0001631","HP:0000248"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":73,"sourceGroups":{"omim":42,"orphanet":31}},"features":[{"hpoId":"HP:0000496","label":"Abnormality of eye movement","primary":true},{"hpoId":"HP:0001274","label":"Agenesis of corpus callosum","primary":true},{"hpoId":"HP:0031882","label":"Agyria","primary":true},{"hpoId":"HP:0007370","label":"Aplasia/Hypoplasia of the corpus callosum","primary":true},{"hpoId":"HP:0001284","label":"Areflexia","primary":true},{"hpoId":"HP:0001631","label":"Atrial septal defect","primary":true},{"hpoId":"HP:0000248","label":"Brachycephaly","primary":true},{"hpoId":"HP:0008981","label":"Calf muscle hypertrophy","primary":false},{"hpoId":"HP:0100490","label":"Camptodactyly of finger","primary":false},{"hpoId":"HP:0000518","label":"Cataract","primary":false},{"hpoId":"HP:0002350","label":"Cerebellar cyst","primary":false},{"hpoId":"HP:0001321","label":"Cerebellar hypoplasia","primary":false},{"hpoId":"HP:0000750","label":"Delayed speech and language development","primary":false},{"hpoId":"HP:0001644","label":"Dilated cardiomyopathy","primary":false},{"hpoId":"HP:0000268","label":"Dolichocephaly","primary":false},{"hpoId":"HP:0002353","label":"EEG abnormality","primary":false},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0003457","label":"EMG abnormality","primary":false},{"hpoId":"HP:0002084","label":"Encephalocele","primary":false},{"hpoId":"HP:0002267","label":"Exaggerated startle response","primary":false},{"hpoId":"HP:0001371","label":"Flexion contracture","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0000501","label":"Glaucoma","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0001360","label":"Holoprosencephaly","primary":false},{"hpoId":"HP:0000238","label":"Hydrocephalus","primary":false},{"hpoId":"HP:0000540","label":"Hypermetropia","primary":false},{"hpoId":"HP:0030046","label":"Hypoglycosylation of alpha-dystroglycan","primary":false},{"hpoId":"HP:0002365","label":"Hypoplasia of the brainstem","primary":false},{"hpoId":"HP:0007348","label":"Hypoplasia of the pyramidal tract","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0001511","label":"Intrauterine growth retardation","primary":false},{"hpoId":"HP:0001339","label":"Lissencephaly","primary":false},{"hpoId":"HP:0000298","label":"Mask-like facies","primary":false},{"hpoId":"HP:0000568","label":"Microphthalmia","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0003560","label":"Muscular dystrophy","primary":false},{"hpoId":"HP:0001685","label":"Myocardial fibrosis","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0000545","label":"Myopia","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0001302","label":"Pachygyria","primary":false},{"hpoId":"HP:0000767","label":"Pectus excavatum","primary":false},{"hpoId":"HP:0001357","label":"Plagiocephaly","primary":false},{"hpoId":"HP:0002126","label":"Polymicrogyria","primary":false},{"hpoId":"HP:0001642","label":"Pulmonic stenosis","primary":false},{"hpoId":"HP:0002093","label":"Respiratory insufficiency","primary":false},{"hpoId":"HP:0000541","label":"Retinal detachment","primary":false},{"hpoId":"HP:0007973","label":"Retinal dysplasia","primary":false},{"hpoId":"HP:0002650","label":"Scoliosis","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0010864","label":"Severe intellectual disability","primary":false},{"hpoId":"HP:0003202","label":"Skeletal muscle atrophy","primary":false},{"hpoId":"HP:0003306","label":"Spinal rigidity","primary":false},{"hpoId":"HP:0000486","label":"Strabismus","primary":false},{"hpoId":"HP:0001669","label":"Transposition of the great arteries","primary":false},{"hpoId":"HP:0007260","label":"Type II lissencephaly","primary":false},{"hpoId":"HP:0002119","label":"Ventriculomegaly","primary":false},{"hpoId":"HP:0000505","label":"Visual impairment","primary":false},{"hpoId":"HP:0001612","label":"Weak cry","primary":false}],"ledeHtml":"Fukuyama congenital muscular dystrophy is an inherited condition that predominantly affects the muscles, brain, and eyes. Congenital muscular dystrophies are a group of genetic conditions that cause muscle weakness and muscle wasting (atrophy) beginning early in life. The signs and symptoms of Fukuyama congenital muscular dystrophy can vary from mild to severe. Fukuyama congenital muscular dystrophy affects the skeletal muscles, which are the muscles the body uses for movement. The signs and symptoms of the disorder typically begin in early infancy and include a weak cry, difficulty feeding, and weak muscle tone (hypotonia). Weakness of the facial muscles often leads to a distinctive facial appearance including droopy eyelids (ptosis) and an open mouth. In childhood, muscle weakness and joint deformities (contractures) restrict movement and interfere with the development of motor skills such as sitting, standing, and walking. Children with mild Fukuyama congenital muscular dystrophy may be able to stand or walk on their own, while those with severe signs and symptoms may not be able to sit without support. Fukuyama congenital muscular dystrophy also impairs brain development. People with this condition often have a brain abnormality called cobblestone lissencephaly, in which the surface of the brain has a bumpy, irregular appearance (like that of cobblestones). These irregularities in the structure of the brain lead to delays in the development of motor skills and speech and moderate to severe intellectual disabilities. Social skills are less severely impaired. More than half of all affected children experience seizures. In some people with Fukuyama congenital muscular dystrophy, vision is impaired. They may also have increased pressure in the eye (glaucoma) or abnormalities in the specialized light-sensitive tissue that lines the back of the eye (retina). Individuals with Fukuyama congenital muscular dystrophy often develop heart problems in adolescence. These heart problems worsen over time. Severely affected individuals may also develop swallowing difficulties that can lead to a bacterial lung infection called aspiration pneumonia. The serious medical problems associated with Fukuyama congenital muscular dystrophy can shorten the life expectancy of someone with this condition.","mondoId":"MONDO:0009678","node":{"canonicalSlug":"muscular-dystrophy-dystroglycanopathy-congenital-with-brain-and-eye-anomalies-type-a-4","comparisons":[{"documentSha256":"3750e8d4995c3acc0ec4505c4d2f46ec44f03476620d689e0d1ddc4df033d368","key":"legacy-muscular-dystrophy-dystroglycanopathy-congenital-with-brain-and-eye-anomalies-type-a-4","kind":"legacy","label":"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","memberIds":["MONDO:0009678"],"mondoId":"MONDO:0009678","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/muscular-dystrophy-dystroglycanopathy-congenital-with-brain-and-eye-anomalies-type-a-4.3750e8d4995c3acc0ec4505c4d2f46ec44f03476620d689e0d1ddc4df033d368.json"},{"documentSha256":"3e6dbbe08f0a5fa15c27b0b79dcb961a4938dbbf1575c7160f22f97818090975","key":"expanded-muscle-eye-brain-disease","kind":"expanded","label":"muscle-eye-brain disease","memberIds":["MONDO:0009364","MONDO:0009667","MONDO:0009678","MONDO:0013154","MONDO:0013157","MONDO:0013158","MONDO:0014022","MONDO:0014071","MONDO:0014140","MONDO:0018939"],"mondoId":"MONDO:0018939","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-3e6dbbe08f0a5fa15c27.3e6dbbe08f0a5fa15c27b0b79dcb961a4938dbbf1575c7160f22f97818090975.json"},{"documentSha256":"9e938372c5990a8aec98ddb0d9e5fdd3c77080997548d471f74c9d4d55873bd8","key":"expanded-muscular-dystrophy-dystroglycanopathy","kind":"expanded","label":"muscular dystrophy-dystroglycanopathy","memberIds":["MONDO:0000171","MONDO:0000172","MONDO:0000173","MONDO:0009364","MONDO:0009667","MONDO:0009678","MONDO:0011688","MONDO:0011787","MONDO:0012138","MONDO:0012248","MONDO:0012699","MONDO:0013049","MONDO:0013154","MONDO:0013155","MONDO:0013156","MONDO:0013157","MONDO:0013158","MONDO:0013159","MONDO:0013160","MONDO:0013161","MONDO:0013162","MONDO:0013440","MONDO:0013835","MONDO:0013904","MONDO:0014022","MONDO:0014023","MONDO:0014071","MONDO:0014101","MONDO:0014120","MONDO:0014140","MONDO:0014141","MONDO:0014142","MONDO:0014474","MONDO:0014489","MONDO:0014683","MONDO:0018276","MONDO:0018278","MONDO:0018280","MONDO:0029135","MONDO:0033556"],"mondoId":"MONDO:0018276","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-9e938372c5990a8aec98.9e938372c5990a8aec98ddb0d9e5fdd3c77080997548d471f74c9d4d55873bd8.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","originalSourceId":"ORPHA:272","paragraphs":["Fukuyama congenital muscular dystrophy is an inherited condition that predominantly affects the muscles, brain, and eyes. Congenital muscular dystrophies are a group of genetic conditions that cause muscle weakness and muscle wasting (atrophy) beginning early in life. The signs and symptoms of Fukuyama congenital muscular dystrophy can vary from mild to severe. Fukuyama congenital muscular dystrophy affects the skeletal muscles, which are the muscles the body uses for movement. The signs and symptoms of the disorder typically begin in early infancy and include a weak cry, difficulty feeding, and weak muscle tone (hypotonia). Weakness of the facial muscles often leads to a distinctive facial appearance including droopy eyelids (ptosis) and an open mouth. In childhood, muscle weakness and joint deformities (contractures) restrict movement and interfere with the development of motor skills such as sitting, standing, and walking. Children with mild Fukuyama congenital muscular dystrophy may be able to stand or walk on their own, while those with severe signs and symptoms may not be able to sit without support. Fukuyama congenital muscular dystrophy also impairs brain development. People with this condition often have a brain abnormality called cobblestone lissencephaly, in which the surface of the brain has a bumpy, irregular appearance (like that of cobblestones). These irregularities in the structure of the brain lead to delays in the development of motor skills and speech and moderate to severe intellectual disabilities. Social skills are less severely impaired. More than half of all affected children experience seizures. In some people with Fukuyama congenital muscular dystrophy, vision is impaired. They may also have increased pressure in the eye (glaucoma) or abnormalities in the specialized light-sensitive tissue that lines the back of the eye (retina). Individuals with Fukuyama congenital muscular dystrophy often develop heart problems in adolescence. These heart problems worsen over time. Severely affected individuals may also develop swallowing difficulties that can lead to a bacterial lung infection called aspiration pneumonia. The serious medical problems associated with Fukuyama congenital muscular dystrophy can shorten the life expectancy of someone with this condition."],"rawAttribution":"MONDO:0009678","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:39:44Z","upstream":"GARD:0006475","url":"https://rarediseases.info.nih.gov/diseases/6475"},"ownColumnKeys":["population-b917fa63703775fadd1c","population-efdf4a81ba85cc1d0fa4"],"publication":"published","relationships":[{"kind":"parent","label":"muscular dystrophy-dystroglycanopathy, type A","mondoId":"MONDO:0000171","slug":"muscular-dystrophy-dystroglycanopathy-type-a"},{"kind":"parent","label":"muscle-eye-brain disease","mondoId":"MONDO:0018939","slug":"muscle-eye-brain-disease"},{"kind":"parent","label":"myopathy caused by variation in FKTN","mondoId":"MONDO:0700067","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"synonym-scope-not-retained","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/fukuyama-congenital-muscular-dystrophy"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"01d6c8dae3effbf4fbb87eb2ce9170df9cb92d3e53ac72192087e762ff88ab5d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003306","is_excluded":false,"label":"Spinal rigidity","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"022bf601fc7f9106e8500ba6b1874e5dc8fa0d297680bc566d84ea88eb4bdb79","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000298","is_excluded":false,"label":"Mask-like facies","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"05fee9cfcb83b88957e7f46992ec0cc9f430fd776fee5f1e8d0ebe92de4a6ae3","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030046","is_excluded":false,"label":"Hypoglycosylation of alpha-dystroglycan","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"106da8d64a54e35ab7db23fe9aa1ca5279a7c0bf1036ed33b3b19cd33f18825e","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002093","is_excluded":false,"label":"Respiratory insufficiency","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"12b2c1b278e9014f7d96a79d17e3b52aaa6811d76d6f68059fc6be77413baf38","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000496","is_excluded":false,"label":"Abnormality of eye movement","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1331cae249c03cdcc42b5ee6fcbdc402178657499fe63b102d68d8352bca8be1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001302","is_excluded":false,"label":"Pachygyria","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"13d3b0cd1ce3510bc4ac82f45941eec3eb2c655877db0188ac659fa8a2b38d37","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001360","is_excluded":false,"label":"Holoprosencephaly","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"16c7459951193b3e5cef9b8de5b6baecc91d5ba6502dc5c2899588cbb5e76720","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000238","is_excluded":false,"label":"Hydrocephalus","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1a4cebca6e9fa3bbce17e49efadd5fae2c688fd6ad9670839fd514548da71548","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001371","is_excluded":false,"label":"Flexion contracture","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"1f1a1a2663c9aa89582b5de2a42db9724d02e43ac1ec0db0bb2470c95ffa3e85","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002350","is_excluded":false,"label":"Cerebellar cyst","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1fc070ba3cb3c7e94181f6654d63232d2e4004e026236c465c9585538c8872fc","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000518","is_excluded":false,"label":"Cataract","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"230b2aef56b6aab13addef357652f80ed8fd21543509a5bb9351f2703f4e79a8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"2345d29d49c9aef0495106b39b25863ada0596d6d0bb87276f80e4296afc9eda","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002650","is_excluded":false,"label":"Scoliosis","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"2fdc5b85846f5ced76b9281c0c814af10e6b072f89b62801ba407fdaff85e64d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3090253e202b0ca3dc059f1836a74de17496040a643ee2d52f947f065301cb32","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000248","is_excluded":false,"label":"Brachycephaly","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"338875fbb8d471e9cbaf05db2c09ea761316941083a4c606ce876ef975127cbe","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000268","is_excluded":false,"label":"Dolichocephaly","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"36db523fefa818bb83a48caec02e110b8debf41ff754c0e2cd46342ca7d7d746","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007260","is_excluded":false,"label":"Type II lissencephaly","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3876023538154185afb72a1831e4d6130417b1d6d581e7f82f86a5a15f184529","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001669","is_excluded":false,"label":"Transposition of the great arteries","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"3cb3c1cf8fc24e176041ccb8741103f45ede92a19d9595485f2d05f3dfef1680","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3ea7315ab9d5df719077b062acfa7ebc9b98a2c976563e465e90068a2805fb0b","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001511","is_excluded":false,"label":"Intrauterine growth retardation","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3fb255b5693c87673d4dbc977fd0540f59142157d1201d1b520e2ed4d4e370fe","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001274","is_excluded":false,"label":"Agenesis of corpus callosum","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"411bb5245af9fc897eece83ec97279ae049b837aed0c5d7d5d94b4dac3c31045","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007973","is_excluded":false,"label":"Retinal dysplasia","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"4170b3594e52edd018eee9aaec1a20eda4421b6990753d233471352665e61dfe","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001644","is_excluded":false,"label":"Dilated cardiomyopathy","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"465b924da815a551cffc229bb698e7c7eb0f18b4549f12a614f5261148e4b08f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002353","is_excluded":false,"label":"EEG abnormality","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"47fd85b053420d164e5ab13e6e16cc0625d5cf95aeeb182d338795102ce18ec6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000238","is_excluded":false,"label":"Hydrocephalus","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4a8118a93ee080c9e558c5603e1b9a07e51caa4bedb40e610d0971f0452d9104","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002126","is_excluded":false,"label":"Polymicrogyria","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4d581d771f77824327cda0d8fa5b817f7aba69265c106c709d3b379c9ca4eeef","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001631","is_excluded":false,"label":"Atrial septal defect","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5035dde5f357c9711ded02dd5e0edd8568c26e5e2e9807be3f9b53c2edb48d69","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007348","is_excluded":false,"label":"Hypoplasia of the pyramidal tract","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"5542cd35e94766727e6e2442b264bdcbdaefea432a00502568e5caf90870e220","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002267","is_excluded":false,"label":"Exaggerated startle response","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"57ca522f0160650b58c3a5fcbfd1b36fa50549b8c25eb07106da703c64b7316e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008981","is_excluded":false,"label":"Calf muscle hypertrophy","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5b74dd1f7f1027057130ce9031873fb4edc4be839299bc9ca9cc7dc2d4a17a5d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002365","is_excluded":false,"label":"Hypoplasia of the brainstem","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"5c742b89d1e6aad08adf5d89b5ed59d4e1c9685ab7abdce40e0adde16e38fa5b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000545","is_excluded":false,"label":"Myopia","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"5c78e932dd6268028ac9582edbdda9da8063d379402292e141f0782bc5925157","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000540","is_excluded":false,"label":"Hypermetropia","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"6ef18b300229a17658c477dbc5c799aeca2d661051b5f3f088ec165a9e903d80","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"755a3f40791f4c2c8516d11d16c40fb907c849c276157896d11adba74f1897bf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001339","is_excluded":false,"label":"Lissencephaly","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"7aee4808364ebb832ab91a6bd1ff06d100bc03d69cc3d9f2f37fbf490d4c16c7","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007973","is_excluded":false,"label":"Retinal dysplasia","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7cd659b613f314d8e7fb494f90c1076a0e72e0fe9afc644d270835e9c8750721","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100490","is_excluded":false,"label":"Camptodactyly of finger","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"884bae46350dc5fa782e9cb3514e3c546aba46b6dbb8f2f3cc70339a996c7cb8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"891b1f7be8e06e90b75477480db250573fc65839f40f6685ceb9efa4da85fa66","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001644","is_excluded":false,"label":"Dilated cardiomyopathy","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"89c11278d512a210eb68617c2b6de66a7cdb33fb0ea6ea6b3e6a0ab0d86c0b53","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001321","is_excluded":false,"label":"Cerebellar hypoplasia","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"90758ddf94bd6ebe5fdc162654f9852c204f43f19164cb8bc254507c1b3a5c0f","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001642","is_excluded":false,"label":"Pulmonic stenosis","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"950c6af690e1900911e03ca9f7fda2e7c4abf47231b9d1a59780172b94aa8edf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"9adcd3a90079607a29feedc20a9190763772c607cc503651ed2c935401078e17","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"9dab69f2b9609fe3f50ba499e9e56b2117cc5ced5fa9af2d96226f480b626402","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"a2dd666ea48d136029f190796852309a45b02b54ad0353ae9751f826ebc32e97","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001371","is_excluded":false,"label":"Flexion contracture","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a3c44e48fcf0a16bca4a4d1092f90f6b0538784a24d118209747038099191524","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000568","is_excluded":false,"label":"Microphthalmia","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"a5a0a99ed900a6d352d721f877e8c5d4af747fd20ff0929bdaee5d37beed90d1","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000767","is_excluded":false,"label":"Pectus excavatum","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ac6b4e5e7c033a56ebf2d5a7069605867c3c69000272d2a09f9a488c444934f2","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000541","is_excluded":false,"label":"Retinal detachment","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"af382f0edccd8a398a6d357a17edcd26b7127571593e7063b41ac1736ff7364d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b67024d16775cb097c1c1bbb1acf849067a6c537d548507dca6d38669ce7fc52","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002084","is_excluded":false,"label":"Encephalocele","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"bf1cf27ff92bd9724d76c6d2ac950b7facf096c1dcee3080614e6419d61131af","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003202","is_excluded":false,"label":"Skeletal muscle atrophy","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"c0e24d3e43169dac8d91470f62c6eabc697a466f6cb03061f95922fa08b136ea","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007370","is_excluded":false,"label":"Aplasia/Hypoplasia of the corpus callosum","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"c610a203ae921f29fadc9709b114371d7f9ed531cf23a00f69fa09e2e4573298","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001685","is_excluded":false,"label":"Myocardial fibrosis","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d1697a181af6eec77c1e9ad9d59b9232f4a663b2ba4048a12a9d5b4877e22cb8","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001357","is_excluded":false,"label":"Plagiocephaly","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d5d2d2a10cd14c18425f66456faeea68b09252ff99674d3c3323bc6faf9c9499","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010864","is_excluded":false,"label":"Severe intellectual disability","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d670c5b9e00cc860307c4ca43a40c2c0ee09957f002d1d69649a4fa18b45ad02","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007260","is_excluded":false,"label":"Type II lissencephaly","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dae35e6611e274cbc1021bcdc02e878963ae9fbe56713a4eb80db5fb05a59bc4","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000518","is_excluded":false,"label":"Cataract","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e0de48ced076affc22cdd5dff604b26e43349e198be9ba3f7c90fa78e88d5d55","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001612","is_excluded":false,"label":"Weak cry","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e10d805c9dc27f9ff16ad583a1500af4d9bd41cdcf66ea50246212534c13ba06","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000501","is_excluded":false,"label":"Glaucoma","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e1160e721c5c3781c4d436cebbc9ae610d696c22f56853887f0c5557f9311554","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000545","is_excluded":false,"label":"Myopia","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e2a872dfa4b9ea0d336bb85c9df198ce22f94c821285179859a29d1aa5f7cedd","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000486","is_excluded":false,"label":"Strabismus","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"e5cb0904ef56c21f0179344643f0c021591a3ec165618405ddda3405a57b307b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e8790b4b3d4f2d85974ce734b2c8befe89cdde06cf103a088789dc3ae5c88739","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e962f74c23726419260fc33e34d1058c6b7f2cb85ae779aecb43fb751ac1e625","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003457","is_excluded":false,"label":"EMG abnormality","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ec15dfdb3042f6223a9e1ceecb9e2de35a7f7dd39541607b7c00b4d1b6d772ec","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001284","is_excluded":false,"label":"Areflexia","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f0c2b834d28e924a8cf54c740e78d7eef0eb4932512003c49361b3935ed18546","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f1172facf764cf9fb526b7201f66cb596234851d8c374ef58f3e514f3e874ba4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f3639f9691df523d5d4baeac49290f046d81fb4de1a7f9c30c58c347ba9d0264","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002119","is_excluded":false,"label":"Ventriculomegaly","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f6a090e8589390d3ff504bf5cf229f3f3df480b03fa2ce089971cf4c1d8f7249","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f9ac13a8d024eddc263dc4c3e81f62ee9e6ec5f75acc0a90e9b70ca225f9a269","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:272","disease_name":"Congenital muscular dystrophy, Fukuyama type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:272","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"fa7c499dc4bcf4b65ac3e978f632b3176466637979aec5fe00756b4004aa95d7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"fe6a843a4eb33abd8bca7d7c912a7ad39ef79429c75bbd94fd94463d253a7b41","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"fe84b132560fd53c92681a3816949bd9f9470e12507991a903f476d5b123092c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253800","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0031882","is_excluded":false,"label":"Agyria","onset_id":null,"reference":"OMIM:253800","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/6475\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009678\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0006475</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Fukuyama congenital muscular dystrophy is an inherited condition that predominantly affects the muscles, brain, and eyes. Congenital muscular dystrophies are a group of genetic conditions that cause muscle weakness and muscle wasting (atrophy) beginning early in life. The signs and symptoms of Fukuyama congenital muscular dystrophy can vary from mild to severe. Fukuyama congenital muscular dystrophy affects the skeletal muscles, which are the muscles the body uses for movement. The signs and symptoms of the disorder typically begin in early infancy and include a weak cry, difficulty feeding, and weak muscle tone (hypotonia). Weakness of the facial muscles often leads to a distinctive facial appearance including droopy eyelids (ptosis) and an open mouth. In childhood, muscle weakness and joint deformities (contractures) restrict movement and interfere with the development of motor skills such as sitting, standing, and walking. Children with mild Fukuyama congenital muscular dystrophy may be able to stand or walk on their own, while those with severe signs and symptoms may not be able to sit without support. Fukuyama congenital muscular dystrophy also impairs brain development. People with this condition often have a brain abnormality called cobblestone lissencephaly, in which the surface of the brain has a bumpy, irregular appearance (like that of cobblestones). These irregularities in the structure of the brain lead to delays in the development of motor skills and speech and moderate to severe intellectual disabilities. Social skills are less severely impaired. More than half of all affected children experience seizures. In some people with Fukuyama congenital muscular dystrophy, vision is impaired. They may also have increased pressure in the eye (glaucoma) or abnormalities in the specialized light-sensitive tissue that lines the back of the eye (retina). Individuals with Fukuyama congenital muscular dystrophy often develop heart problems in adolescence. These heart problems worsen over time. Severely affected individuals may also develop swallowing difficulties that can lead to a bacterial lung infection called aspiration pneumonia. The serious medical problems associated with Fukuyama congenital muscular dystrophy can shorten the life expectancy of someone with this condition.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/6475\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"muscular-dystrophy-dystroglycanopathy-congenital-with-brain-and-eye-anomalies-type-a-4","sourceDocuments":[{"name":"GARD: Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","reviewed":null,"source_release":"2026-10-25T03:39:44Z","url":"https://rarediseases.info.nih.gov/diseases/6475"},{"name":"MONDO: muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009678"}],"sourceNote":"","synonyms":["FCMD","Fukuyama congenital muscular dystrophy","Fukuyama Type Congenital Muscular Dystrophy","MDDGA4","muscle-eye-brain-FKTN related","muscular dystrophy-dystroglycanopathy (congenital with Brain and eye anomalies) type A, 4","muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4","Walker-Warburg syndrome or muscle-eye-brain disease, FKTN-related"],"takeawayHtml":"","title":"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4"},"schemaVersion":1}
